302 related articles for article (PubMed ID: 27703330)
1. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
Nam JH; Oh M; Kim HJ; Han SK; Kim EJ; Song GS; Kim EY; Shin JG; Ghim JL; Kim HS
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):66-74. PubMed ID: 25034618
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
9. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
Moon SJ; Jeon JY; Yu KS; Kim MG
Clin Ther; 2019 Nov; 41(11):2273-2282. PubMed ID: 31564513
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
Rohatagi S; Lee J; Shenouda M; Haworth S; Bathala MS; Allison M; Rubets I; Heyrman R; Noveck R; Salazar DE
J Clin Pharmacol; 2008 Nov; 48(11):1309-22. PubMed ID: 18974285
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and haemodynamic interactions between amlodipine and losartan in human beings.
Park JW; Kim KA; Il Kim Y; Park JY
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):345-352. PubMed ID: 31058419
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components.
Jeon I; Moon SJ; Park SI; Choi Y; Jung J; Yu KS; Chung JY
Clin Pharmacol Drug Dev; 2022 Jan; 11(1):91-99. PubMed ID: 34159751
[TBL] [Abstract][Full Text] [Related]
17. Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects.
Sunkara G; Jiang X; Reynolds C; Serra D; Zhang Y; Ligueros-Saylan M; Ayalasomayajula S; Winter S; Jarugula V
Clin Pharmacol Drug Dev; 2014 Nov; 3(6):487-92. PubMed ID: 27129123
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
Oh M; Ghim JL; Park SE; Kim EY; Shin JG
Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
[TBL] [Abstract][Full Text] [Related]
20. No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects.
Kim JR; Kim S; Huh W; Ko JW
Drug Des Devel Ther; 2018; 12():2475-2483. PubMed ID: 30127595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
